Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 435

1.

Coagulation Differences Detectable in Deep and Lobar Primary Intracerebral Hemorrhage Using Thromboelastography.

Roh D, Torres GL, Cai C, Zammit C, Reynolds AS, Mitchell A, Connolly ES, Claassen J, Grotta JC, Choi HA, Chang TR.

Neurosurgery. 2020 Mar 13. pii: nyaa056. doi: 10.1093/neuros/nyaa056. [Epub ahead of print]

PMID:
32167143
2.

Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.

Agarwal S, Scher E, Lord A, Frontera J, Ishida K, Torres J, Rostanski S, Mistry E, Mac Grory B, Cutting S, Burton T, Silver B, Liberman AL, Lerario MP, Furie K, Grotta J, Khatri P, Saver J, Yaghi S.

Stroke. 2020 Apr;51(4):1226-1230. doi: 10.1161/STROKEAHA.119.027476. Epub 2020 Feb 27.

PMID:
32102629
3.

Endovascular Thrombectomy for Acute Ischemic Strokes: Current US Access Paradigms and Optimization Methodology.

Sarraj A, Savitz S, Pujara D, Kamal H, Carroll K, Shaker F, Reddy S, Parsha K, Fournier LE, Jones EM, Sharrief A, Martin-Schild S, Grotta J.

Stroke. 2020 Apr;51(4):1207-1217. doi: 10.1161/STROKEAHA.120.028850. Epub 2020 Feb 12.

PMID:
32078480
4.

Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis.

Malhotra K, Katsanos AH, Goyal N, Ahmed N, Strbian D, Palaiodimou L, Karapanayiotides T, Alexandrov AW, Grotta JC, Alexandrov AV, Tsivgoulis G.

Neurology. 2020 Feb 18;94(7):e657-e666. doi: 10.1212/WNL.0000000000008961. Epub 2020 Jan 20.

PMID:
31959709
5.

Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection.

Sarraj A, Hassan AE, Grotta J, Sitton C, Cutter G, Cai C, Chen PR, Imam B, Pujara D, Arora A, Reddy S, Parsha K, Riascos RF, Vora N, Abraham M, Edgell R, Hellinger F, Haussen DC, Blackburn S, Kamal H, Barreto AD, Martin-Schild S, Lansberg M, Gupta R, Savitz S, Albers GW.

Ann Neurol. 2020 Mar;87(3):419-433. doi: 10.1002/ana.25669. Epub 2020 Jan 21.

PMID:
31916270
6.

Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist.

Berekashvili K, Zha AM, Abdel-Al M, Zhang X, Soomro JH, Prater SJ, Grotta JC.

Stroke. 2020 Feb;51(2):663-665. doi: 10.1161/STROKEAHA.119.026948. Epub 2019 Nov 27.

PMID:
31771461
7.

Stroke in the elderly.

Sharrief A, Grotta JC.

Handb Clin Neurol. 2019;167:393-418. doi: 10.1016/B978-0-12-804766-8.00021-2.

PMID:
31753145
8.

Cocaine Use is Associated with More Rapid Clot Formation and Weaker Clot Strength in Acute Stroke Patients.

Almaghrabi TS, McDonald MM, Cai C, Rahbar MH, Choi HA, Lee K, Naval NS, Grotta JC, Chang TR.

Int J Cerebrovasc Dis Stroke. 2019;2(1). pii: 110. Epub 2019 Jan 18.

9.

Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series.

Peacock WF, Grotta JC, Steiner T.

J Emerg Med. 2019 Dec;57(6):e167-e173. doi: 10.1016/j.jemermed.2019.09.038. Epub 2019 Oct 26.

10.

Machine Learning-Enabled Automated Determination of Acute Ischemic Core From Computed Tomography Angiography.

Sheth SA, Lopez-Rivera V, Barman A, Grotta JC, Yoo AJ, Lee S, Inam ME, Savitz SI, Giancardo L.

Stroke. 2019 Nov;50(11):3093-3100. doi: 10.1161/STROKEAHA.119.026189. Epub 2019 Sep 24.

PMID:
31547796
11.

Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.

Vahidy FS, Haque ME, Rahbar MH, Zhu H, Rowan P, Aisiku IP, Lee DA, Juneja HS, Alderman S, Barreto AD, Suarez JI, Bambhroliya A, Hasan KM, Kassam MR, Aronowski J, Gee A, Cox CS Jr, Grotta JC, Savitz SI.

Stem Cells. 2019 Nov;37(11):1481-1491. doi: 10.1002/stem.3080. Epub 2019 Sep 17.

PMID:
31529663
12.

Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.

Lerario MP, Grotta JC, Merkler AE, Omran SS, Chen ML, Parikh NS, Yaghi S, Murthy S, Navi BB, Kamel H.

Stroke. 2019 Nov;50(11):3283-3285. doi: 10.1161/STROKEAHA.119.026861. Epub 2019 Sep 13.

PMID:
31514696
13.

Direct Assessment of Health Utilities Using the Standard Gamble Among Patients With Primary Intracerebral Hemorrhage.

Slaughter KB, Meyer EG, Bambhroliya AB, Meeks JR, Ahmed W, Bowry R, Behrouz R, Mir O, Begley C, Tyson JE, Miller C, Warach S, Grotta JC, McCullough LD, Savitz SI, Vahidy FS.

Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e005606. doi: 10.1161/CIRCOUTCOMES.119.005606. Epub 2019 Sep 13.

PMID:
31514521
14.

Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study.

Sarraj A, Hassan AE, Savitz S, Sitton C, Grotta J, Chen P, Cai C, Cutter G, Imam B, Reddy S, Parsha K, Pujara D, Riascos R, Vora N, Abraham M, Kamal H, Haussen DC, Barreto AD, Lansberg M, Gupta R, Albers GW.

JAMA Neurol. 2019 Jul 29. doi: 10.1001/jamaneurol.2019.2109. [Epub ahead of print]

PMID:
31355873
15.

Emergency Department Door-to-Puncture Time Since 2014.

Czap AL, Grotta JC, Parker SA, Yamal JM, Bowry R, Sheth SA, Rajan SS, Hwang H, Singh N, Bratina P, Bryndziar T, Alexandrov AV, Alexandrov AW, Dusenbury W, Swatzell V, Jones W, Ackerson K, Schimpf B, Wright P, Jagolino-Cole AL.

Stroke. 2019 Jul;50(7):1774-1780. doi: 10.1161/STROKEAHA.119.025106. Epub 2019 Jun 11.

PMID:
31182000
16.

14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and summary of discussions.

Sheth SA, Lopez-Rivera V, Lee S, Savitz SI, Liebeskind DS, Grotta JC; Thrombolysis, Thrombectomy and Acute Stroke Therapy (TTST) group.

Int J Stroke. 2019 Jun;14(4):439-441. doi: 10.1177/1747493019838760. Epub 2019 Mar 28.

PMID:
30920353
17.

Interhospital Transfer of Stroke Patients for Endovascular Treatment.

Grotta JC.

Circulation. 2019 Mar 26;139(13):1578-1580. doi: 10.1161/CIRCULATIONAHA.118.039425. No abstract available.

PMID:
30908102
18.

Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.

Alexandrov AV, Köhrmann M, Soinne L, Tsivgoulis G, Barreto AD, Demchuk AM, Sharma VK, Mikulik R, Muir KW, Brandt G, Alleman J, Grotta JC, Levi CR, Molina CA, Saqqur M, Mavridis D, Psaltopoulou T, Vosko M, Fiebach JB, Mandava P, Kent TA, Alexandrov AW, Schellinger PD; CLOTBUST-ER Trial Investigators.

Lancet Neurol. 2019 Apr;18(4):338-347. doi: 10.1016/S1474-4422(19)30026-2.

PMID:
30878103
19.

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack.

Wang Y, Johnston SC, Bath PM, Grotta JC, Pan Y, Amarenco P, Wang Y, Simon T, Kim JS, Jeng JS, Liu L, Lin Y, Wong KSL, Wang D, Li H.

BMJ. 2019 Feb 28;364:l895. doi: 10.1136/bmj.l895. No abstract available.

20.

Real-World Treatment Trends in Endovascular Stroke Therapy.

Saber H, Navi BB, Grotta JC, Kamel H, Bambhroliya A, Vahidy FS, Chen PR, Blackburn S, Savitz SI, McCullough L, Sheth SA.

Stroke. 2019 Mar;50(3):683-689. doi: 10.1161/STROKEAHA.118.023967.

21.

Endovascular Thrombectomy for Mild Strokes: How Low Should We Go?

Sarraj A, Hassan A, Savitz SI, Grotta JC, Cai C, Parsha KN, Farrell CM, Imam B, Sitton CW, Reddy ST, Kamal H, Goyal N, Elijovich L, Reishus K, Krishnan R, Sangha N, Wu A, Costa R, Malik R, Mir O, Hasan R, Snodgrass LM, Requena M, Graybeal D, Abraham M, Chen M, McCullough LD, Ribo M.

Stroke. 2018 Oct;49(10):2398-2405. doi: 10.1161/STROKEAHA.118.022114.

22.

Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).

Berekashvili K, Soomro J, Shen L, Misra V, Chen PR, Blackburn S, Dannenbaum M, Grotta JC, Barreto AD.

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3647-3651. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.036. Epub 2018 Sep 21.

23.

Intraosseous Administration of Tissue Plasminogen Activator on a Mobile Stroke Unit.

Bowry R, Nour M, Kus T, Parker S, Stephenson J, Saver J, Grotta JC, Ostermayer D.

Prehosp Emerg Care. 2019 Jul-Aug;23(4):447-452. doi: 10.1080/10903127.2018.1526355. Epub 2018 Oct 25.

PMID:
30235055
24.

Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

Al-Shahi Salman R, Frantzias J, Lee RJ, Lyden PD, Battey TWK, Ayres AM, Goldstein JN, Mayer SA, Steiner T, Wang X, Arima H, Hasegawa H, Oishi M, Godoy DA, Masotti L, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Jang DK, Davalos A, Castillo J, Yao X, Claassen J, Volbers B, Kazui S, Okada Y, Fujimoto S, Toyoda K, Li Q, Khoury J, Delgado P, Sabín JÁ, Hernández-Guillamon M, Prats-Sánchez L, Cai C, Kate MP, McCourt R, Venkatasubramanian C, Diringer MN, Ikeda Y, Worthmann H, Ziai WC, d'Esterre CD, Aviv RI, Raab P, Murai Y, Zazulia AR, Butcher KS, Seyedsaadat SM, Grotta JC, Martí-Fàbregas J, Montaner J, Broderick J, Yamamoto H, Staykov D, Connolly ES, Selim M, Leira R, Moon BH, Demchuk AM, Di Napoli M, Fujii Y, Anderson CS, Rosand J; VISTA-ICH Collaboration; ICH Growth Individual Patient Data Meta-analysis Collaborators.

Lancet Neurol. 2018 Oct;17(10):885-894. doi: 10.1016/S1474-4422(18)30253-9. Epub 2018 Aug 14. Erratum in: Lancet Neurol. 2018 Sep 19;:.

25.

Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) Project.

Balucani C, Arnedo V, Weedon J, Leys D, Mas JL, Brown M, Grotta JC, Gonzales NR, Hacke W, Brott T, Levine SR.

Neurohospitalist. 2018 Jul;8(3):113-123. doi: 10.1177/1941874417747772. Epub 2018 Jan 17.

26.

To Treat or Not to Treat?

Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C.

Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971.

PMID:
29976582
27.

Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage.

Blackburn SL, Kumar PT, McBride D, Zeineddine HA, Leclerc J, Choi HA, Dash PK, Grotta J, Aronowski J, Cardenas JC, Doré S.

Front Physiol. 2018 May 31;9:592. doi: 10.3389/fphys.2018.00592. eCollection 2018. Review.

28.

Antiplatelet Therapy after Ischemic Stroke or TIA.

Grotta JC.

N Engl J Med. 2018 Jul 19;379(3):291-292. doi: 10.1056/NEJMe1806043. Epub 2018 May 16. No abstract available.

PMID:
29766754
29.

Time to Decision and Treatment With tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit.

Bowry R, Parker SA, Yamal JM, Hwang H, Appana S, Rangel-Gutierrez N, Wu TC, Rajan SS, Grotta JC.

Stroke. 2018 Jun;49(6):1528-1530. doi: 10.1161/STROKEAHA.117.020585. Epub 2018 May 2.

PMID:
29720439
30.

HeadPoST: Rightly positioned, or flat out wrong?

Alexandrov AW, Tsivgoulis G, Hill MD, Liebeskind DS, Schellinger P, Ovbiagele B, Arthur AS, Caso V, Nogueira RG, Hemphill JC 3rd, Grotta JC, Hacke W, Alexandrov AV.

Neurology. 2018 May 8;90(19):885-889. doi: 10.1212/WNL.0000000000005481. Epub 2018 Apr 11. Review.

PMID:
29643083
31.

Thrombelastography Suggests Hypercoagulability in Patients with Renal Dysfunction and Intracerebral Hemorrhage.

Meier K, Saenz DM, Torres GL, Cai C, Rahbar MH, McDonald M, Fraser S, Espino E, Choi HA, Edwards NJ, Lee K, Grotta JC, Chang TR.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1350-1356. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.026. Epub 2018 Feb 12.

PMID:
29449126
32.

Delivery of xenon-containing echogenic liposomes inhibits early brain injury following subarachnoid hemorrhage.

Miao YF, Peng T, Moody MR, Klegerman ME, Aronowski J, Grotta J, McPherson DD, Kim H, Huang SL.

Sci Rep. 2018 Jan 11;8(1):450. doi: 10.1038/s41598-017-18914-6.

33.

Bringing Emergency Neurology to Ambulances: Mobile Stroke Unit.

Bowry R, Grotta JC.

Semin Respir Crit Care Med. 2017 Dec;38(6):713-717. doi: 10.1055/s-0037-1607994. Epub 2017 Dec 20. Review.

PMID:
29262428
34.

Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.

Hacke W, Lyden P, Emberson J, Baigent C, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis SM, Donnan GA, Grotta JC, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Olivot JM, Parsons M, Sandercock PA, Toni D, Toyoda K, Wahlgren N, Wardlaw JM, Whiteley WN, Del Zoppo G, Lees KR; Stroke Thrombolysis Trialists’ Collaborators Group.

Int J Stroke. 2018 Feb;13(2):175-189. doi: 10.1177/1747493017744464. Epub 2017 Nov 24. Erratum in: Int J Stroke. 2018 Feb;13(2):NP3.

PMID:
29171359
35.

Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke.

McDonald MM, Almaghrabi TS, Saenz DM, Cai C, Rahbar MH, Choi HA, Lee K, Grotta JC, Chang TR.

J Intensive Care Med. 2020 Jan;35(1):68-73. doi: 10.1177/0885066617729644. Epub 2017 Sep 21.

PMID:
28931362
36.

The PRE-hospital Stroke Treatment Organization.

Audebert H, Fassbender K, Hussain MS, Ebinger M, Turc G, Uchino K, Davis S, Alexandrov A, Grotta J; PRESTO Group.

Int J Stroke. 2017 Dec;12(9):932-940. doi: 10.1177/1747493017729268. Epub 2017 Sep 5. Review.

PMID:
28872449
37.

Telemedicine-guided education on secondary stroke and fall prevention following inpatient rehabilitation for Texas patients with stroke and their caregivers: a feasibility pilot study.

Jhaveri MM, Benjamin-Garner R, Rianon N, Sherer M, Francisco G, Vahidy F, Kobayashi K, Gaber M, Shoemake P, Vu K, Trevino A, Grotta J, Savitz S.

BMJ Open. 2017 Sep 3;7(9):e017340. doi: 10.1136/bmjopen-2017-017340.

38.

Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".

Barreto AD, Grotta JC.

Stroke. 2017 Sep;48(9):e259. doi: 10.1161/STROKEAHA.117.018294. Epub 2017 Jul 28. No abstract available.

39.

Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.

Reddy ST, Cossey TC, Savitz SI, Grotta JC.

Curr Neurol Neurosci Rep. 2017 Sep;17(9):67. doi: 10.1007/s11910-017-0774-6. Review.

PMID:
28735353
40.

Rethinking Training and Distribution of Vascular Neurology Interventionists in the Era of Thrombectomy.

Grotta JC, Lyden P, Brott T.

Stroke. 2017 Aug;48(8):2313-2317. doi: 10.1161/STROKEAHA.116.016416. Epub 2017 Jul 13. No abstract available.

PMID:
28706124
41.

Benefits of stroke treatment delivered using a mobile stroke unit trial.

Yamal JM, Rajan SS, Parker SA, Jacob AP, Gonzalez MO, Gonzales NR, Bowry R, Barreto AD, Wu TC, Lairson DR, Persse D, Tilley BC, Chiu D, Suarez JI, Jones WJ, Alexandrov A, Grotta JC.

Int J Stroke. 2018 Apr;13(3):321-327. doi: 10.1177/1747493017711950. Epub 2017 Jun 14. Erratum in: Int J Stroke. 2018 Apr;13(3):NP4.

PMID:
28612680
42.

Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).

Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, Rahbar MH, Grotta JC; ARTSS-2 Investigators.

Stroke. 2017 Jun;48(6):1608-1616. doi: 10.1161/STROKEAHA.117.016720. Epub 2017 May 15.

43.

Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.

Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL.

Lancet Neurol. 2017 Mar;16(3):227-237. doi: 10.1016/S1474-4422(17)30008-X. Epub 2017 Feb 15. Review. Erratum in: Lancet Neurol. 2017 Apr;16(4):261.

PMID:
28229894
44.

Telemedicine Can Replace the Neurologist on a Mobile Stroke Unit.

Wu TC, Parker SA, Jagolino A, Yamal JM, Bowry R, Thomas A, Yu A, Grotta JC.

Stroke. 2017 Feb;48(2):493-496. doi: 10.1161/STROKEAHA.116.015363. Epub 2017 Jan 12.

PMID:
28082671
45.

Agreement Among Stroke Faculty and Fellows in Treating Ischemic Stroke Patients With Tissue-Type Plasminogen Activator and Thrombectomy.

Ramadan AR, Denny MC, Vahidy F, Yamal JM, Wu TC, Sarraj A, Savitz S, Grotta J.

Stroke. 2017 Jan;48(1):222-224. doi: 10.1161/STROKEAHA.116.015214. Epub 2016 Nov 22.

PMID:
27879445
46.

Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2).

Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, Parker S, Concha M, Hussain S, Agarwal S, Meyer B, Jurf J, Altafullah I, Raman R; Collaborators.

Stroke. 2016 Dec;47(12):2888-2895. Epub 2016 Nov 10.

47.

Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population.

Kim JT, Fonarow GC, Smith EE, Reeves MJ, Navalkele DD, Grotta JC, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Saver JL.

Circulation. 2017 Jan 10;135(2):128-139. doi: 10.1161/CIRCULATIONAHA.116.023336. Epub 2016 Nov 4.

PMID:
27815374
48.

Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).

von Kummer R, Mori E, Truelsen T, Jensen JS, Grønning BA, Fiebach JB, Lovblad KO, Pedraza S, Romero JM, Chabriat H, Chang KC, Dávalos A, Ford GA, Grotta J, Kaste M, Schwamm LH, Shuaib A, Albers GW; DIAS-4 Investigators.

Stroke. 2016 Dec;47(12):2880-2887. Epub 2016 Nov 1.

PMID:
27803391
49.

Sex Disparities in Access to Acute Stroke Care: Can Telemedicine Mitigate this Effect?

Wolff C, Boehme AK, Albright KC, Wu TC, Mullen MT, Branas CC, Grotta JC, Savitz SI, Carr BG.

J Health Dispar Res Pract. 2016 Spring;9(1). pii: 5.

50.

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.

Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group.

Stroke. 2016 Sep;47(9):2373-9. doi: 10.1161/STROKEAHA.116.013644. Epub 2016 Aug 9.

Supplemental Content

Loading ...
Support Center